DOAC and carbamazepine — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Carbamazepine may reduce apixaban exposure and anticoagulant effect
Carbamazepine is a strong enzyme inducer and can reduce exposure to some DOACs, risking loss of anticoagulant effect. This is clinically important because inadequate anticoagulation in AF increases stroke risk. The prescriber should review anticoagulant choice and neuralgia treatment. INR is not used for routine apixaban dose adjustment.
Reference: BNF